Role of PYK2 in the development of obesity and insulin resistance

Ying Yu1, Stuart A Ross, Amy E Halseth

  • 1PFIZER Global Research and Development, Cardiovascular Pharmacology, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA.

Insights

Proline-rich tyrosine kinase-2 (PYK2) may slow obesity and insulin resistance. Mice lacking PYK2 gained more weight and showed worse glucose intolerance on a high-fat diet, suggesting a protective role for PYK2.

Area of Science:

  • Molecular Biology
  • Metabolic Diseases
  • Cell Signaling

Background:

  • Non-receptor proline-rich tyrosine kinase-2 (PYK2) is involved in glucose transport regulation.
  • PYK2's role in insulin resistance and obesity is debated, with some studies suggesting a positive role and others implicating it in insulin resistance induction.

Purpose of the Study:

  • To investigate the role of PYK2 in obesity and insulin resistance.
  • To evaluate PYK2 regulation in mice fed a high-fat diet.
  • To characterize body and glucose homeostasis in wild-type (WT) and PYK2 knockout (PYK2(-/-)) mice.

Main Methods:

  • Mice were fed a high-fat diet for 8 weeks to induce obesity and insulin resistance.
  • PYK2 expression and phosphorylation were analyzed in liver and adipose tissues.
  • Body weight, fasting serum leptin, insulin, blood glucose, and glucose tolerance were assessed in WT and PYK2(-/-) mice.

Main Results:

  • High-fat diet increased PYK2 expression and phosphorylation in liver and adipose tissues.
  • PYK2(-/-) mice gained significantly more weight than WT mice on a high-fat diet.
  • PYK2(-/-) mice exhibited exacerbated glucose intolerance compared to WT mice on a high-fat diet.

Conclusions:

  • The absence of PYK2 worsens diet-induced weight gain and glucose intolerance.
  • PYK2 appears to play a protective role in slowing the development of obesity and insulin resistance.
  • These findings suggest PYK2 could be a therapeutic target for metabolic disorders.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...